SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-090549
Filing Date
2020-08-05
Accepted
2020-08-05 07:00:34
Documents
48
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bcli-20200630x10q.htm   iXBRL 10-Q 930967
2 EXHIBIT 10.1 bcli-20200630xex10d1.htm EX-10.1 16829
3 EXHIBIT 10.2 bcli-20200630xex10d2.htm EX-10.2 9839
4 EXHIBIT 31.1 bcli-20200630xex31d1.htm EX-31.1 9835
5 EXHIBIT 31.2 bcli-20200630xex31d2.htm EX-31.2 9834
6 EXHIBIT 32.1 bcli-20200630xex32d1.htm EX-32.1 5674
7 EXHIBIT 32.2 bcli-20200630xex32d2.htm EX-32.2 5708
  Complete submission text file 0001104659-20-090549.txt   3261018

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE bcli-20200630.xsd EX-101.SCH 25369
9 XBRL CALCULATION FILE bcli-20200630_cal.xml EX-101.CAL 27654
10 XBRL DEFINITION FILE bcli-20200630_def.xml EX-101.DEF 84985
11 XBRL LABEL FILE bcli-20200630_lab.xml EX-101.LAB 210977
12 XBRL PRESENTATION FILE bcli-20200630_pre.xml EX-101.PRE 182971
13 EXTRACTED XBRL INSTANCE DOCUMENT bcli-20200630x10q_htm.xml XML 395947
Mailing Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019
Business Address 1325 AVENUE OF AMERICAS 28TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36641 | Film No.: 201075575
SIC: 2836 Biological Products, (No Diagnostic Substances)